NCT07508020RecruitingPhase 1
A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity
Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 14 Jan 2026
- Start date
- 19 Mar 2026
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Obesity
- EU CT number
- 2025-521393-34-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 120
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Parexel International GmbH Coordinator of this site? Confirm its status | Berlin | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.